Gestational Trophoblastic Neoplasia Group 1
Gestational Trophoblastic Neoplasia Group 1
Gestational Trophoblastic Neoplasia Group 1
TROPHOBLASTIC
NEOPLASIA
GROUP 1
DEFINITION:
Gestational trophoblastic disease (GTD) is a heterogeneous spectrum of diseases with proliferation ranging from benign to malignant state.
Persistent GTD (persistently raised b-hCG) is referred as gestational trophoblastic neoplasia (GTN).
Diagnosis of post molar GTN is made when the hCG level plateaus for 3 or more consecutive weeks or re-elevates. This may occur in 15-20% following hyadatidiform mole.
RISK FACTORS FOR DEVELOPMENT OF GTN
Postmolar GTN of serious nature may be either invasive mole or choriocarcinoma but GTN after non-molar
pregnancy is always a choriocarcinoma.
GTN includes :
• invasive mole/post molar GTN
• Choriocarcinoma
• Placental site trophoblastic tumor (PSTT)
• Epitheloid trophoblastic tumor (ETT)
Incidence
More than 50 percent occur after molar pregnancy, about 25 percent after abortion and/or ectopic
pregnancy and a few after normal pregnancy. Non-metastatic (locally invasive) lesions develop in 15 percent
and metastatic lesions develop in about 4 percent of patients after molar evacuation.
SPREAD OF GTN: Apart from the local spread, vascular erosion takes place early and hence distant
metastases occur rapidly. The common sites of metastases are lungs (80%), anterior vaginal wall (30%), brain
(10%), liver (10%) and others.
Signs:
• Patient looks ill.
• Pallor of varying degrees.